Epigenetic Stress and Chromate Carcinogenesis
表观遗传应激和铬酸盐致癌
基本信息
- 批准号:9768470
- 负责人:
- 金额:$ 49.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAcetylationAffectAnimal ModelBindingBinding SitesBiological AssayCRISPR/Cas technologyCarcinogensCellsCellular StressChIP-seqChromatesChromatinChromatin StructureChromiumChronicDNADNA Modification MethylasesDataEnzymesEpigenetic ProcessEpithelialExposure toFormaldehydeGene ExpressionGenesGenetic TranscriptionGrantHistone Deacetylase InhibitorHistonesHumanInhalationKnock-outKnockout MiceMalignant NeoplasmsMalignant neoplasm of liverMalignant neoplasm of lungMalignant neoplasm of pancreasMapsMediatingMolecular WeightNuclear ProteinNude MiceOccupationalPlayPromoter RegionsProteinsRegulatory ElementRoleSmall Interfering RNAStressTechniquesTranscription Factor AP-1Transcriptional ActivationTransposaseWaterWild Type Mousebasecarcinogenesiscarcinogenicitycell transformationchromium hexavalent iondaltongenome-wideinsightknock-downlung developmentoverexpressionpreventprogramspromoterstressortranscription factortranscriptome sequencingtumorzinc chromate
项目摘要
PROJECT SUMMARY
Hexavalent Chromium (Cr(VI)) has been shown to cause lung cancer in humans when inhaled, with little
known about the epigenetic mechanisms responsible for Cr(VI)-induced carcinogenesis. Nupr1 (nuclear
protein 1) is a small, highly basic, and unfolded protein with molecular weight of 8,800 daltons, which is
induced by a variety of stressors. Our preliminary data indicate that the level of Nupr1 is significantly increased
in human bronchial epithelial BEAS2B cells following exposure to Cr(VI). Cr(VI)-induced activation of Nupr1
might be controlled by epigenetic regulators and AP1 transcription factors, since (i) Nupr1 transcription is
increased by treating cells with inhibitors of histone deacetylases or DNA methyltransferase; (ii) Cr(VI) was
found by FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) to open chromatin domains around
AP1 binding sites and ChIP-seq results (ENCODE) show the binding of AP1 factors around the promoter
region of Nupr1. Our preliminary results demonstrate that overexpression of Nupr1 increases the levels of
transcriptional active mark histone H3K4 trimethylation (H3K4me3) but decreases the levels of H4K16
acetylation (H4K16ac) – a hallmark of cancers, indicating that induction of Nupr1 is attributable to Cr(VI)-
mediated gain of H3K4me3 and loss of H4K16ac. The importance of Nupr1 in the Cr(VI)-induced changes in
H3K4me3 and H4K16ac was further supported by the fact that knockdown of Nupr1 by siRNA greatly
compromised the increase of H3K4me3 and the loss of H4K16ac following Cr(VI) exposure. Importantly,
overexpression of Nupr1 induced transformation of BEAS2B cells, while knockdown of Nupr1 inhibited
Cr(VI)-induced cell transformation. We hypothesize that Cr(VI) induces Nupr1 via changes in epigenetic
status and AP1 transcription factor binding in the promoter of Nupr1 gene and rapidly perturbs chromatin
structure and gene expression by altering H4K16ac and/or H3K4me3, thereby contributing to Cr(VI)-induced
carcinogenesis. We will explore these hypotheses through three specific aims. In Aim 1, we will determine
mechanisms that regulate Cr(VI)-mediated induction of Nupr1. In Aim 2, We will determine the Nupr1-
dependent Cr(VI)-responsive changes in chromatin structure and gene expression. We will further characterize
transformation-related genes dysregulated by Cr(VI) exposure through induction of Nupr1 by comparing
transcriptional profiles of transformed BEAS2B cells induced by overexpression of Nupr1 or Cr(VI) treatment.
In Aim 3, we will study whether knockout of Nupr1 expression prevents cell transformation and tumor formation
in nude mice induced by Cr(VI). We will also investigate the carcinogenicity of chronic Cr(VI) exposure in wild-
type mice and in Nupr1-knockout mice.
项目摘要
六价铬(Cr(VI))已被证明在人类吸入时会导致肺癌,
已知的表观遗传机制负责铬(VI)诱导的致癌作用。Nupr 1(核
蛋白质1)是小的、高碱性的、未折叠的蛋白质,分子量为8,800道尔顿,
由各种压力源引起的。我们的初步数据表明,Nupr 1的水平显着增加,
在暴露于Cr(VI)后的人支气管上皮BEAS 2B细胞中。Cr(VI)诱导的Nupr 1激活
可能受表观遗传调节因子和AP 1转录因子控制,因为(i)Nupr 1转录是
通过用组蛋白去乙酰化酶或DNA甲基转移酶的抑制剂处理细胞而增加;(ii)Cr(VI)
FAIRE(甲醛辅助分离调控元件)发现,
AP 1结合位点和ChIP-seq结果(ENCODE)显示启动子周围的AP 1因子的结合
Nupr 1的区域。我们的初步结果表明,Nupr 1的过表达增加了
转录活性标记组蛋白H3 K4三甲基化(H3 K4 me 3),但降低H4 K16的水平
乙酰化(H4 K16 ac)-癌症的标志,表明Nupr 1的诱导可归因于Cr(VI)-
介导H3 K4 me 3的获得和H4 K16 ac的丧失。Nupr 1在Cr(VI)诱导的细胞内变化中的重要性
H3 K4 me 3和H4 K16 ac进一步得到以下事实的支持,即通过siRNA敲低Nupr 1极大地抑制了H3 K4 me 3和H4 K16 ac。
损害了Cr(VI)暴露后H3 K4 me 3的增加和H4 K16 ac的损失。重要的是,
Nupr 1过表达诱导BEAS 2B细胞转化,而Nupr 1敲低抑制BEAS 2B细胞转化。
Cr(VI)诱导的细胞转化。我们假设Cr(VI)通过改变表观遗传学来诱导Nupr 1。
Nupr 1基因启动子中的状态和AP 1转录因子结合,并快速干扰染色质
通过改变H4 K16 ac和/或H3 K4 me 3的结构和基因表达,从而有助于Cr(VI)诱导的
致癌作用我们将通过三个具体目标来探讨这些假设。在目标1中,我们将确定
调节Cr(VI)介导的Nupr 1诱导的机制。在目标2中,我们将确定Nupr 1-
染色质结构和基因表达的依赖性Cr(VI)响应性变化。我们将进一步描述
通过比较,通过诱导Nupr 1,通过Cr(VI)暴露失调的转化相关基因
通过过表达Nupr 1或Cr(VI)处理诱导的转化BEAS 2B细胞的转录谱。
在目标3中,我们将研究敲除Nupr 1表达是否阻止细胞转化和肿瘤形成。
在Cr(VI)诱导的裸鼠中。我们还将研究慢性Cr(VI)暴露在野生动物中的致癌性-
型小鼠和Nupr 1敲除小鼠中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Max Costa其他文献
Max Costa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Max Costa', 18)}}的其他基金
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10077549 - 财政年份:2020
- 资助金额:
$ 49.05万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
9899647 - 财政年份:2020
- 资助金额:
$ 49.05万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10515635 - 财政年份:2020
- 资助金额:
$ 49.05万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10294236 - 财政年份:2020
- 资助金额:
$ 49.05万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10470848 - 财政年份:2019
- 资助金额:
$ 49.05万 - 项目类别:
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
砷致癌和组蛋白变体 H3.3 组装的破坏
- 批准号:
10407027 - 财政年份:2019
- 资助金额:
$ 49.05万 - 项目类别:
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure
由于环境镍暴露,MEG3 缺失导致肺部肿瘤发生
- 批准号:
9852426 - 财政年份:2019
- 资助金额:
$ 49.05万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10004646 - 财政年份:2019
- 资助金额:
$ 49.05万 - 项目类别:
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
砷致癌和组蛋白变体 H3.3 组装的破坏
- 批准号:
10631227 - 财政年份:2019
- 资助金额:
$ 49.05万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10681242 - 财政年份:2019
- 资助金额:
$ 49.05万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 49.05万 - 项目类别: